Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase II Study of Chemoradiation and Pembrolizumab for Locally Advanced Cancer

NCT02635360 is registered in ClinicalTrials.gov with Linda R Duska as lead sponsor.

NCT NCT02635360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02635360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase II Study of Chemoradiation and Pembrolizumab for Locally Advanced Cancer
Lead sponsor
Linda R Duska
Phase
Phase 2
Overall status
Completed
Start date
February 9, 2017
Completion date
December 14, 2022
Enrollment
94 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer